Companies · Other Health Care

Corus Orthodontists Inc.

CALGARY · Other Health Care

Diligence memoA one-page analyst read on Corus Orthodontists Inc. — recommendation, valuation, rhythm, risks.
$38.5M
Total raised · real
9
Rounds
0.5×
Latest step-up
Top 11%
Sector rank · raised
Series B
Latest stage · inferred · Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Corus Orthodontists Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.13× the median modeled value of Series B Other Health Care companies in 2019–2021 (78 peers) — value vs value, same stage and era.
Dormant
  • Last raise 4.7 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Corus Orthodontists Inc. is one of 5376 Other Health Care companies tracked from CALGARY. By capital raised it ranks among the largest (ahead of 90% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2019
Year incorporated
2021-10-19
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeries B · 2020-12-21 Raised $17M (real) Modeled valuation $327M (est)Series B2020Series B · 2020-12-21 Raised $17M (real) Modeled valuation $327M (est)Series B2020Series B · 2021-05-11 Raised $7.3M (real) Modeled valuation $124M (est)Series B2021Series B · 2021-05-25 Raised $466K (real) Modeled valuation $7.8M (est)Series B2021Series B · 2021-06-17 Raised $407K (real) Modeled valuation $6.7M (est)Series B2021Pre-Seed · 2021-07-08 Raised $238K (real) Modeled valuation $4.4M (est)Pre-Seed2021Series B · 2021-07-08 Raised $2.3M (real) Modeled valuation $38M (est)Series B2021Seed · 2021-08-19 Raised $1.0M (real) Modeled valuation $16M (est)Seed2021Series B · 2021-08-19 Raised $1.2M (real) Modeled valuation $19M (est)Series B2021Pre-Seed · 2021-09-01 Raised $472K (real) Modeled valuation $8.1M (est)Pre-Seed2021Series B · 2021-09-01 Raised $472K (real) Modeled valuation $7.3M (est)Series B2021Series B · 2021-09-14 Raised $6.1M (real) Modeled valuation $93M (est)Series B2021Series B · 2021-10-19 Raised $3.2M (real) Modeled valuation $48M (est)Series B2021Cumulative $57M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$17.1M · 2020
Series B extension$17.1M · 2020
Series B extension$7.3M · 2021
Series B extension$466K · 2021
Series B extension$407K · 2021
Bridge · Series B-stage$238K · 2021smaller follow-on
Series B extension$2.3M · 2021
Bridge · Series B-stage$1.0M · 2021smaller follow-on
Series B extension$1.2M · 2021
Bridge · Series B-stage$472K · 2021smaller follow-on
Series B extension$472K · 2021
Series B extension$6.1M · 2021
Series B extension$3.2M · 2021

Stages are modeled from round size (public records carry no series label). No record for: Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.

Modeled valuation trajectory
$48.0M
Base estimate est.
$7.6M
Conservative case
$144.0M
Upside case
$17.9M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series B · modeled $327.0M · 2020-12-212020Series B · modeled $327.0M · 2020-12-21Series B · modeled $123.9M · 2021-05-11Series B · modeled $7.8M · 2021-05-25Series B · modeled $6.7M · 2021-06-17Pre-Seed · modeled $4.4M · 2021-07-08Series B · modeled $38.1M · 2021-07-08Seed · modeled $15.5M · 2021-08-19Series B · modeled $19.0M · 2021-08-19Pre-Seed · modeled $8.1M · 2021-09-01Series B · modeled $7.3M · 2021-09-01Series B · modeled $93.1M · 2021-09-14Series B · modeled $48.0M · 2021-10-192021
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
4.7 yr
Elapsed time used
4.7 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
1 mo
Avg between rounds
$46.6M/yr
Capital velocity
5.5 yr
On record since
2020
First round
13
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 16× above median
This company$38.5M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.2× of median
This company$3.2M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 2.2× above median
This company$48.0M
Sector median$22.1M

Raised more than 90% of sector peers (real $). Modeled value above 66% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #70 of 78.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0B$10.0M$100.0MCapital raised (log)KSMS Holdings, LLC · Series B Raised $40.0M · modeled $885.1M (est)Infab HoldCo, Inc. · Series B Raised $36.5M · modeled $807.5M (est)Aquity Holdings, Inc. · Series B Raised $36.0M · modeled $797.6M (est)MHH Management Holdco, LLC · Series B Raised $35.1M · modeled $777.6M (est)Earli Inc. · Series B Raised $40.0M · modeled $756.4M (est)Encore Dermatology, Inc. · Series B Raised $89.6M · modeled $729.9M (est)National Spine & Pain Centers Holdings, LLC · Series B Raised $32.0M · modeled $708.9M (est)In Vitro Sciences, LLC · Series B Raised $31.5M · modeled $697.9M (est)Lotus Parent, Inc. · Series B Raised $31.2M · modeled $690.4M (est)Iron Oak Holdings LLC · Series B Raised $30.0M · modeled $664.6M (est)Squid Ink, Inc. · Series B Raised $30.2M · modeled $620.8M (est)Predict Innovation Investors, Llc · Series B Raised $27.9M · modeled $617.4M (est)Corus Orthodontists Inc. (this company) Raised $38.5M · modeled $48.0M (est)Corus Orthodontists Inc.
CompanyStageRaised · realValue · estvs peer med.
KSMS Holdings, LLCSeries B$40.0M$885.1M2.37×
Infab HoldCo, Inc.Series B$36.5M$807.5M2.16×
Aquity Holdings, Inc.Series B$36.0M$797.6M2.13×
MHH Management Holdco, LLCSeries B$35.1M$777.6M2.08×
Earli Inc.Series B$40.0M$756.4M2.02×
Encore Dermatology, Inc.Series B$89.6M$729.9M1.95×
National Spine & Pain Centers Holdings, LLCSeries B$32.0M$708.9M1.90×
In Vitro Sciences, LLCSeries B$31.5M$697.9M1.87×
Lotus Parent, Inc.Series B$31.2M$690.4M1.85×
Iron Oak Holdings LLCSeries B$30.0M$664.6M1.78×
Squid Ink, Inc.Series B$30.2M$620.8M1.66×
Predict Innovation Investors, LlcSeries B$27.9M$617.4M1.65×
Corus Orthodontists Inc. this companySeries B$38.5M$48.0M0.13×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$17.1M2020-12-21$94.8M$327.0M90%
Series B$17.1M2020-12-21$94.8M$327.0M90%
Series B$7.3M2021-05-11$40.4M$123.9M90%
Series B$466K2021-05-25$2.6M$7.8M90%
Series B$407K2021-06-17$2.3M$6.7M90%
Pre-Seed$238K2021-07-08$1.3M$4.4M90%
Series B$2.3M2021-07-08$13.0M$38.1M90%
Seed$1.0M2021-08-19$5.1M$15.5M90%
Series B$1.2M2021-08-19$6.7M$19.0M90%
Pre-Seed$472K2021-09-01$2.6M$8.1M90%
Series B$472K2021-09-01$2.6M$7.3M90%
Series B$6.1M2021-09-14$33.7M$93.1M90%
Series B$3.2M2021-10-19$17.9M$48.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$17.1M2020-12-21
    • First recorded raise — entered as Series B.
    • 8 investors on this round.
  2. Series B$17.1M2020-12-21
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 8 investors on this round.
  3. Series B$7.3M2021-05-11
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 2.3× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  4. Series B$466K2021-05-25
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 15.6× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  5. Series B$407K2021-06-17
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
  6. Pre-Seed$238K2021-07-08
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 1.7× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  7. Series B$2.3M2021-07-08
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 9.9× larger than the prior — scaling up.
    • 1 investor on this round.
  8. Seed$1.0M2021-08-19
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 2.3× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  9. Series B$1.2M2021-08-19
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
  10. Pre-Seed$472K2021-09-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.6× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  11. Series B$472K2021-09-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
  12. Series B$6.1M2021-09-14
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 12.9× larger than the prior — scaling up.
    • 1 investor on this round.
  13. Series B$3.2M2021-10-19
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 1.9× smaller than the prior — bridge or down round.
    • 1 investor on this round.
Intelligence
2021 ~Q4
Modeled next raise · ~1mo cadence
$3.2M
Modeled next size est.range $3.2M$5.2M
0.5×
Last step-up
$46.6M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Nick Korhonen2020-12
Registry & provenance

Corus Orthodontists Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1846182
SEC CIK
2019
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Center for Orthopedic & Research Excellence, Inc.Other Health CareSeries B$38.2M$48.7Msame sector · same stage
PreciseDx, Inc.Other Health CareSeries B$32.0M$55.7Msame sector · same stage
MindCare Solutions Group, Inc.Other Health CareSeries B$30.5M$55.4Msame sector · same stage
EvidenceCare, Inc.Other Health CareSeries B$28.0M$50.7Msame sector · same stage
Amalgam Rx, Inc.Other Health CareSeries B$27.3M$36.8Msame sector · same stage
Her M.D., Inc.Other Health CareSeries B$26.4M$52.4Msame sector · same stage
PrognomIQ, Inc.Other Health CareSeries B$56.2M$49.0Msame sector · same stage
RIMSYS Inc.Other Health CareSeries B$24.2M$37.5Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Signature Orthodontics Inc.Other Health CareSeries A$103.3M88%
CoapTech, Inc.Other Health CareSeries A$32.2M84%
WildSmiles Braces, LLCOther Health CarePre-Seed$9.2M83%
CorSanitas, Inc.Other Health CarePre-Seed$10.9M83%
Klowen Braces, Inc.Other Health CareSeries B$31.9M83%
Denteractive Solutions, Inc.Other Health CarePre-Seed$6.2M83%
Ceramic Orthopedics Inc.Other Health CareSeed$3.1M83%
OrthoPreserve, Inc.Other Health CarePre-Seed$327K83%
Frequently asked
How much funding has Corus Orthodontists Inc. raised?
Corus Orthodontists Inc. has raised approximately $38.5M in disclosed capital across 9 recorded financing rounds, aggregated from public filings.
What is Corus Orthodontists Inc.'s estimated valuation?
Provath's modeled valuation for Corus Orthodontists Inc. is approximately $48.0M (modeled range $7.6M–$144.0M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Corus Orthodontists Inc. at?
Corus Orthodontists Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Tue Oct 19.
What does Corus Orthodontists Inc. do and where is it based?
Corus Orthodontists Inc. operates in the Other Health Care sector, based in CALGARY.
Explore related

See where Corus Orthodontists Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Corus Orthodontists Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.